Medicus Pharma Ltd., a pharmaceutical holding company, through its subsidiary Skinject Inc., engages in the developing and commercializing novel non-invasive treatment for basal cell and squamous cell skin cancer. It uses its patented dissolvable microneedle patch to deliver chemotherapeutic agent to eradicate tumors cells. The company was founded in 2015 and is based in Toronto, Canada.